SIM
TEVA icon

Sonora Investment Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Sonora Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-400
Closed -$4K – 1784
2020
Q3 		$4K Buy
+400
New +$4.23K ﹤0.01% 1529
2019
Q2 		– Sell
-794
Closed -$12K – 1744
2019
Q1 		$12K Hold
794
– – ﹤0.01% 951
2018
Q4 		$12K Buy
794
+54
+7% +$1.11K ﹤0.01% 782
2018
Q3 		$16K Buy
740
+565
+323% +$13.1K ﹤0.01% 713
2018
Q2 		$4K Hold
175
– – ﹤0.01% 998
2018
Q1 		$2.99K Buy
+175
New +$3.42K ﹤0.01% 1018
2017
Q4 		– Sell
-150
Closed -$2.64K – 1225
2017
Q3 		$2.64K Sell
150
-149
-50% -$3.35K ﹤0.01% 952
2017
Q2 		$9.93K Buy
+299
New +$9.26K ﹤0.01% 729

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Sonora Investment Management's TEVA Position: Q4 2020 in Review

Sonora Investment Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2020, closing a stake of 400 shares — an estimated $4K sold.

Sonora Investment Management first reported a position in TEVA in Q2 2017 and held it in 8 quarters. The position peaked at $16K in Q3 2018. 450 funds tracked by Wall St. Rank hold TEVA as of Q4 2020.

  • Sonora Investment Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2020 after selling out during the quarter.
  • Sonora Investment Management sold 400 Teva Pharmaceutical Industries Limited shares in Q4 2020, an estimated $4K.
  • Sonora Investment Management first reported a position in Teva Pharmaceutical Industries Limited in Q2 2017 and held it in 8 quarters.
  • Sonora Investment Management's Teva Pharmaceutical Industries Limited position peaked at $16K in Q3 2018.
  • 450 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2020.

Based on Sonora Investment Management's 13F filing for Q4 2020, filed 13 Jan 2021.